Abiomed Chairman, President and CEO Michael R. Minogue Named Chairman of AdvaMed Board of Directors
Minogue, Whitaker to host press conference March 11 to discuss AdvaMed priorities
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed), the world’s largest trade association for medical technology and supply companies, announced that today Abiomed Chairman, President and Chief Executive Officer Michael R. Minogue was elected Chairman of the AdvaMed Board of Directors for a two-year term, effective today. AdvaMed is also announcing that it will host a virtual press conference with reporters on Thursday, March 11, at noon Eastern to introduce Chairman Minogue and AdvaMed President and CEO Scott Whitaker’s priorities for the association and industry going forward. (Email Jim Jeffries to RSVP.)
Mr. Minogue has been a member of the AdvaMed Board of Directors since 2007 and a member of the Board Executive Committee since 2009, during which time he has served on several committees, including those overseeing membership, inclusion and diversity, payment policy, ethics, and international policy. In 2011, Mr. Minogue was elected as the first Chairman of the newly created Emerging Growth Company Council, which later became AdvaMed Accel, the division within AdvaMed dedicated to the needs of smaller medical technology manufacturers. Mr. Minogue served as the Chairman of the Accel Board of Directors until 2014. In 2012, Mr. Minogue and AdvaMed co-founded MedTechVets.org, and he served as Chairman until 2019.
Mr. Minogue has been the Chairman, President, and CEO of Abiomed for 17 years. Before that, he spent 11 years with General Electric Medical Systems, where he held numerous leadership positions and was awarded three patents. Mr. Minogue also served as an Infantry Officer in the U.S. Army, with multiple distinctions including Airborne, Ranger, Desert Storm Veteran, and Bronze Star. He received his Bachelor of Science degree in engineering management from the United States Military Academy at West Point and his Master of Business Administration from the University of Chicago.
Mr. Minogue said: “This past year, the medical technology community rose to the challenge presented by COVID-19. Our companies produced the PPE, diagnostic COVID-19 tests, and medical devices needed to help COVID-19 patients. Our employees continued to make life-saving products and support hospitals all over the world. I’m humbled and thankful for the opportunity to serve as Chairman of Advamed during this time. I hope to help our industry continue to improve and save patients’ lives.”
As Chairman, Minogue plans to strengthen the association’s and industry’s focus on patients and the impact AdvaMed companies make in patients’ lives. Minogue will also build upon outgoing Chairman Kevin Lobo’s leadership and successful work to improve inclusion and diversity throughout the industry, with the added component of expanding the recruitment from our nation’s military veterans. MedTechVets is a nonprofit organization that assists and prepares transitioning service members and military veterans for employment in the medical device industry. “Our nation’s military veterans are highly diverse and have a desire to continue to serve a purpose. This makes veterans an ideal match for our industry that is committed to serving others around the world,” said Mr. Minogue.
AdvaMed President and CEO Scott Whitaker said of Mr. Minogue: “There’s no one better prepared to lead this association for the next two years than Mike. As a leader in our industry for more than two decades with a career that spans small, midsize, and larger company perspectives, and with his distinguished service in the military, Mike brings tremendous experience, and a focus on patients that I know will benefit them and the companies innovating on their behalf. Mike’s emphasis on putting patients first is a great example for our industry, and I know I speak for the entire Board when I say we look forward to his leadership.”
Minogue succeeds Stryker Chairman and CEO Kevin Lobo.
Mr. Whitaker said of Mr. Lobo: “Kevin led our association through the most difficult time our industry has seen in our lifetime. Kevin’s leadership was crucial—steady, innovative, and forward thinking. Under his leadership, AdvaMed rallied to respond to the COVID-19 pandemic, from ensuring supply of critical medical supplies, such as PPE and diagnostic tests, to partnering with Government to ensure timely granting of emergency use approvals. He also championed diversity, equity and inclusion as well as patient advocacy. We thank him for his leadership and guidance, which will have a lasting impact on the industry and the patients we serve.”
AdvaMed accomplishments under the leadership of Kevin Lobo as chairman include:
- Creation of the MedDevice Network, to connect our companies with suppliers outside our industry to improve our ability meet the high demand for crucial COVID-related medical supplies
- Creation of the COVID-19 Testing Supply Registry to help the federal and state governments get a better understanding of the nation’s testing needs
- Full repeal of the $2-billion-a-year medical device excise tax
- Secured federal establishment of a new coverage pathway – MCIT – for breakthrough medical technologies
- Launch of The Story of MedTech, which now hosts nearly 100 unique stories about patients who have benefited from medical technology innovation
- Introduction of Safety.AdvaMed.Org, which describes the rigorous safety and efficacy standards medical technologies are held to
- Release of a new research study, Modernizing Medicare Coverage of Digital Health Technologies, which outlines steps CMS, HHS, and Congress might take to modernize the Medicare framework for coverage and payment of digital health technologies
- Launch of AdvaMed Advance, an industry convener dedicated to improving inclusion and diversity standards across the industry
- Unanimous Board approval of AdvaMed’s Principles on Health Equity
Additionally, the following members were elected to the AdvaMed Board of Directors today:
- Sharon Wolfington of Acumed
- Norman Schwartz of Bio-Rad
- Carl St. Bernard of CeloNova Biosciences
- Shacey Petrovic of Insulet
- Tom McGuinness of Microsoft
- Lishan Aklog of PAVmed
- Todd Pope of WellAir
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.